痴呆患者临终替代决策中的预立医疗照护计划与临终照护趋势
该研究基于健康与退休研究(HRS)2000–2014年数据,分析70岁及以上痴呆、临终需替代决策并死亡者共870人(加权N=2,812,380)。结果显示仅34.8%完成全部三项预立医疗照护计划(ACP),且2000–2014年间ACP完成率无显著增加;临终生命延长治疗每年增加1.4个百分点(95%CI 0.5–2.2,P=0.002),院内死亡、限制或撤除治疗及舒适导向照护比例无变化。
要点
- 痴呆临终需替代决策者中仅34.8%完成全部三项ACP,2000–2014年无显著增加。
- 临终生命延长治疗使用逐年增加,年均增1.4个百分点(95%CI 0.5–2.2,P=0.002)。
- 院内死亡、限制或撤除治疗及舒适导向照护比例随时间无显著变化。
核心结论
- 尽管ACP可能有益,痴呆临终需替代决策者的ACP完成率未随时间增加,生命延长治疗仍常见。
研究设计与样本
- 基于HRS全国代表性纵向面板研究,纳入70岁及以上痴呆、临终需替代决策且2000–2014年死亡者870人(加权N=2,812,380),由替代决策者死后报告评估。
主要发现
- 仅34.8%患者完成全部三项ACP,2000–2014年间ACP完成率无显著增加。
- 临终生命延长治疗接受率随时间增加,调整后年均变化1.4个百分点(95%CI 0.5–2.2,P-for-trend=0.002)。
- 院内死亡、限制或撤除某些治疗及接受舒适导向照护的比例无显著变化。
关键数值与推荐
- ACP完成定义为三项患者参与内容:书面临终照护指示、指定医疗持久授权代理人、患者参与临终照护讨论。
- 临终照护强度指标包括:院内死亡、接受生命延长治疗、限制或撤除某些治疗、接受舒适导向照护。
临床怎么用
- 对痴呆患者应尽早启动ACP,尤其针对临终可能需替代决策者,以促进照护意愿表达。
- 关注临终生命延长治疗使用增加趋势,在替代决策时充分权衡患者价值观与治疗获益。
局限性
- ACP与临终照护指标基于替代决策者死后报告,可能存在回忆偏倚。
- 研究为观察性趋势分析,无法推断因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies have demonstrated positive impacts of advance care planning (ACP) on end-of-life (EOL) care. We sought to examine trends in ACP and EOL care intensity among persons living with dementia who required surrogate decision-making in their final days of life. METHODS: We analyzed the participants of the Health and Retirement Study (HRS), a nationally representative longitudinal panel study of U.S. residents, with dementia 70 years and older who required surrogate decision-making in the final days of life and died between 2000 and 2014. Based on surrogate reports after the death of a participant, our study measured the completion of three specific types of patient-engaged ACP (written EOL care instructions, assignment of a durable power of attorney for healthcare, patient engagement in EOL care discussions) and four measures of EOL care in the final days of life (death in hospital, receipt of life-prolonging treatments, limiting or withholding certain treatments, and receipt of comfort-oriented care). All analyses accounted for the complex survey design of HRS. RESULTS: Among 870 adults (weighted N = 2,812,380) with dementia who died in 2000-2014 and required surrogate decision-making at EOL, only 34.8% of patients participated in all three aspects of ACP, and there was not a significant increase in ACP completion between 2000 and 2014. The receipt of life-prolonging treatments in the final days of life has increased over time (adjusted change per year, 1.4 percentage points [pp]; 95% CI, 0.5 to 2.2 pp; P-for-trend = 0.002), while the percentage of death in hospital, limiting or withholding certain treatments, or comfort-oriented care did not change. CONCLUSIONS: Our findings suggest that the rates of ACP completion have not increased over time despite its potential benefits and life-prolonging treatments are still common among PLWD who require surrogate decision-making, a population who might benefit greatly from early ACP.
引用
- Gotanda H, Walling AM, Reuben DB, et al. Trends in advance care planning and end-of-life care among persons living with dementia requiring surrogate decision-making. J Am Geriatr Soc. 2022. PMID: 35122231. doi:10.1111/jgs.17680
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。